$2.44
$-0.13 (-5.06%)
End-of-day quote: 04/18/2024
NasdaqGM:CVAC
CureVac N.V. Annual Report
| Year | Year | 2022 | 2021 | 2020 | |||
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$67.42M | $102.99M | $48.87M | ||
| GM % | Gross Margin % |
|
-135.79% | -109.02% | 71.10% | ||
| OM | Operating Margin |
|
0.00% | 0.00% | -273.27% | ||
| EPS | Earnings Per Share |
|
$0.00 | $-0.93 | $-1.32 | $-4.18 | $-0.98 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | ||
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | ||
| Sha. | Shares |
|
194.95m | 187.12m | 180.46m | ||
| OCF | Operating Cash Flow |
|
$-286.18M | $-733.13M | $522.40M | ||
| FCF | Free Cash Flow |
|
$-374.20M | $-857.35M | $486.07M | ||
| FCFS | Free Cash Flow Per Share |
|
$-2.01 | $-4.63 | $3.59 |
